The National Women’s Health Network is warning all women about the health risks of the new “pink pill” – known as flibanserin and branded as Addyi – alleged to boost female libido. Rather than rely on drug company marketing, NWHN...

This year, the Food and Drug Administration (FDA) made history — for all the wrong reasons.

FOR IMMEDIATE RELEASE Contact: Christina Cherel at ccherel@nwhn.org or (202) 682-2640

Learn about Addyi (flibanserin) and Vyleesi (bremelanotide), FDA-approved drugs designed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. Updated: Sep 1, 2019

I’m disappointed and you should be too. Today, the Food & Drug Administration announced the approval of flibanserin, a proposed treatment for “hypoactive sexual desire disorder” in women. Since its founding, the National Women’s Health Network has ensured that the...

FOR IMMEDIATE RELEASE Contact: Christina Cherel at ccherel@nwhn.org or (202) 682-2640

I’m sure you’ve turned on the television and seen ads marketing drugs for male sexual dysfunction like Viagra. The pharmaceutical industry spends millions marketing these drugs for men, but have…

Learn about 5 common myths surrounding sex drugs like Addyi and Viagra as well as the FDA’s approach to this issue. Updated: Oct 6, 2018

For the first time ever, a committee of scientific advisors has recommended the FDA approve a libido drug for women. “Female Viagra” could be on pharmacy shelves by early next year if the FDA follows that recommendation.

FOR IMMEDIATE RELEASE  Contact: Cindy Pearson at 301-938-0356 or Coco Jervis at 202-407-0788